Adagio Medical Holdings Growth Metrics (2023-2024) | ADGM

Growth Metrics Dec2023 Mar2024 Jun2024 Sep2024
Growth Ratios
Capital Expenditures (QoQ) 710.00%8.02%230.29%
Cash from Investing Activities (QoQ) -710.00%-8.02%-230.29%
Cash from Operations (QoQ) 5.08%-3.29%8.06%
EBITDA Margin Growth (1y) 2.90M
EBITDA Margin (QoQ) 1.52M-1.98M2.86M0.50M
EBIT Growth (1y) 51.27%
EBIT Margin Growth (1y) 1.88M
EBIT Margin (QoQ) 1.53M-2.71M3.13M-0.07M
EBIT (QoQ) 41.27%-65.29%24.46%33.55%
EBT Growth (1y) 50.92%
EBT Margin Growth (1y) 1.98M
EBT Margin (QoQ) 1.58M-2.92M3.39M-0.06M
EBT (QoQ) 38.22%-61.92%22.48%36.71%
EPS (Basic) Growth (1y) 101.27%
EPS (Basic) (QoQ) 19.93%9.27%28.50%102.45%
EPS (Weighted Average and Diluted) Growth (1y) 100.14%
EPS (Weighted Average and Diluted) (QoQ) 19.93%9.27%28.50%100.27%
FCF Margin (QoQ) -1.74M2.37M-0.25M
Free Cash Flow (QoQ) 3.08%-3.41%2.21%
Gross Margin Growth (1y) 0.03M
Gross Margin (QoQ) 0.02M-0.17M0.18M-0.00M
Gross Profit Growth (1y) -33.02%
Gross Profit (QoQ) -20.75%-101.56%17.05%34.11%
Interest Coverage Ratio Growth (1y) 45.67%
Interest Coverage Ratio (QoQ) 50.64%-26.49%25.05%-16.10%
Net Cash Flow (QoQ) 592.62%-177.30%-238.08%
Net Income Growth (1y) 50.92%
Net Income (QoQ) 38.22%-61.92%22.48%36.71%
Net Income towards Common Stockholders Growth (1y) 50.92%
Net Income towards Common Stockholders (QoQ) 38.22%-61.92%22.48%36.71%
Net Margin Growth (1y) 1.98M
Net Margin (QoQ) 1.58M-2.92M3.39M-0.06M
Operating Income Growth (1y) 51.27%
Operating Income (QoQ) 41.27%-65.29%24.46%33.55%
Operating Margin Growth (1y) 1.88M
Operating Margin (QoQ) 1.53M-2.71M3.13M-0.07M
Profit After Tax Growth (1y) 133.51%
Profit After Tax (QoQ) 19.79%7.10%28.49%162.89%
Return on Equity (QoQ) 63.00
Return on Sales Growth (1y) 0.02M
Return on Sales (QoQ) 0.02M-0.03M0.03M-636.00
Revenue Growth (1y) 221.95%
Revenue (QoQ) 90.24%-66.67%876.92%-48.03%
Share-based Compensation (QoQ) -2.65%0.91%
Shareholder's Equity (QoQ) -7.17%0.69%154.49%